Clinical Trials Logo

Invasive Cryptococcosis clinical trials

View clinical trials related to Invasive Cryptococcosis.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT01656382 Withdrawn - Clinical trials for Invasive Cryptococcosis

Safety, Efficacy, and Pharmacokinetics of Amphotericin B Lipid Complex

Start date: January 2007
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if initial therapy with ABLC at 10/mg/kg/d for 7 days are at least effective as ABLC at 5.0 mg/kg/d X 14 days as induction treatment of patients with disseminated cryptococcosis and HIV.